Serotonin Uptake InhibitorsFluoxetineCitalopramParoxetineSerotoninNorepinephrineAntidepressive Agents, Second-GenerationAntidepressive AgentsAntidepressive Agents, TricyclicFluvoxamineSertralineSerotonin Plasma Membrane Transport ProteinsAdrenergic Uptake InhibitorsCyclohexanolsSerotonin SyndromeDepressive DisorderReceptor, Serotonin, 5-HT1AReceptors, SerotoninSerotonin AntagonistsDepressive Disorder, MajorNorepinephrine Plasma Membrane Transport ProteinsReceptors, Serotonin, 5-HT1ClomipramineDesipramineNeurotransmitter Uptake InhibitorsSerotonin Receptor AgonistsReceptor, Serotonin, 5-HT2AObsessive-Compulsive DisorderPremenstrual SyndromeDepressionSerotonin 5-HT1 Receptor Antagonists1-NaphthylamineReceptor, Serotonin, 5-HT1BDothiepinLofepramine8-Hydroxy-2-(di-n-propylamino)tetralinSerotonin AgentsSerotonergic NeuronsSerotonin 5-HT2 Receptor AntagonistsReceptors, Serotonin, 5-HT2Raphe NucleiSerotonin 5-HT1 Receptor AgonistsBehavior, AnimalFenfluramineMaprotilineTryptophan HydroxylaseAnti-Anxiety AgentsDrug InteractionsMonoamine Oxidase InhibitorsMicrodialysisDose-Response Relationship, DrugRats, Sprague-DawleyMianserinToxicity Tests, SubacuteAnxiety DisordersSerotonin 5-HT4 Receptor AgonistsDouble-Blind MethodSwimmingTreatment OutcomeSuicidePsychiatric Status Rating ScalesNortriptylineCognitive TherapyPregnancy ComplicationsReceptor, Serotonin, 5-HT2CBiogenic MonoaminesPiperazinesAmitriptylineAnxietyPropylaminesDroxidopaDepressive Disorder, Treatment-ResistantBrainAntipsychotic AgentsAutoreceptors5-HydroxytryptophanSexual Dysfunction, Physiological5,7-DihydroxytryptamineImipraminePanic DisorderDopamine Uptake InhibitorsThiophenesDopamineMoclobemidePatient DropoutsMotor ActivityAnalysis of VariancePhenelzineReceptor, Serotonin, 5-HT2BBupropionPregnancy TrimestersTime FactorsRandomized Controlled Trials as TopicPsychotropic DrugsPsychotherapyMembrane Transport ProteinsPlacebosCyclobutanesDepersonalizationHindlimb Suspension